Skip to main content
Hashem El-Serag, MD, Gastroenterology, Houston, TX, St. Luke's Health - Baylor St. Luke's Medical Center

HashemBeshirEl-SeragMDMPH

Gastroenterology Houston, TX

Professor and Chairman, Department of Medicine at Baylor College of Medicine Chief, Gastroenterology & Hepatology

Dr. El-Serag is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. El-Serag's full profile

Already have an account?

Summary

  • Hashem B. El-Serag, MD, MPH
    Margaret M. and Albert B. Alkek Chair of the Department of Medicine
    Baylor College of Medicine Houston, Texas

    Hashem B. El-Serag, MD, MPH, obtained his medical degree from Al-Arab Medical University in Libya, completed his internship and residency in internal medicine (1995) at Greenwich Hospital, Yale University, Connecticut, and completed a fellowship in clinical gastroenterology (1997) at the University of New Mexico, Albuquerque, New Mexico, where he also earned a master’s degree in public health (1998). In 1999, Dr. El-Serag joined the Michael E. DeBakey VA Medical Center and Baylor College of Medicine in Houston, where he become chief of the Section of Gastroenterology and Hepatology (2007-2016), leader of the clinical epidemiology and outcomes program at Houston Center for Quality of Care and Utilization Studies (2005-2013), leader of Cancer Prevention and Population Sciences at Dan L Duncan Cancer Center (2009-2015) and Director of NIH funded Texas Medical Center Digestive Disease Center (2013-to date). Effective January 1, 2017 he will be the new Chairman of the Department of Medicine, Baylor College of Medicine.

    Dr. El-Serag’s research focuses on the clinical epidemiology and outcomes of several digestive disorders, including GERD, Barrett's esophagus, esophageal adenocarcinoma, hepatocellular carcinoma and hepatitis C. His seminal work on hepatocellular carcinoma, “Rising Incidence of Hepatocellular Carcinoma in the United States,” was published in 1999 in the New England Journal of Medicine and has been cited more than 3000 times. Dr. El-Serag has more than 400 published articles. Several of his studies were published in notable journals, such as the New England Journal of Medicine, Annals of Internal Medicine, Gastroenterology, Hepatology, and Gut. Dr. El-Serag has obtained more than 50 research grants including multiple continuous funding from the National Institutes of Health and Veteran Affairs, Cancer Preven
  • Hashem El-Serag - Wikipedia

    El-Serag was born in 1966 in Libya to Palestinian parents from the Gaza Strip. He received his M.D. from Al-Arab Medical University in Benghazi, Libya. He then

Education & Training

  • University of New Mexico
    University of New MexicoMPH, 1997 - 1998
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineFellowship, Gastroenterology, 1995 - 1997
  • Greenwich Hospital Association
    Greenwich Hospital AssociationResidency, Internal Medicine, 1993 - 1995
  • Other
    OtherClass of 1991
  • Garyounis University Faculty of Medicine
    Garyounis University Faculty of MedicineClass of 1991
  • Al-Arab Medical University
    Al-Arab Medical UniversityNon-degree, 1983 - 1984

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2000 - 2024
  • NM State Medical License
    NM State Medical License 1995 - 2000
  • CT State Medical License
    CT State Medical License 1994 - 1995

Awards, Honors, & Recognition

  • Bin Qurrah Award, National Arab American Medical Association NAAMA, 2016
  • Michael E. DeBakey Excellence in Research Award Baylor College of Medicine, 2016
  • “World Most Influential Scientific Minds, 2014” in the area of Clinical Medicine by Thompson Reuter 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations  
    Thrift AP, El-Serag HB, Clin Gastroenterol Hepatol, 1/31/2015
  • Reply  
    Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, El-Serag HB, Kanwal F, Clin Gastroenterol Hepatol, 1/10/2015
  • Comparison of endoscopic ultrasound guided 22-gauge core needle with standard 25-gauge fine-needle aspiration for diagnosing solid pancreatic lesions  
    Berzosa M, Villa N, El-Serag HB, Sejpal DV, Patel KK, Endosc Ultrasound, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Incidence and Predictors of Hepatocellular Carcinoma following Sustained Virological Response: A National Cohort Study.
    El-Serag HB, Richardson P, Kanwal F, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
  • Costs per Diagnosed Liver Disease Stage among Individuals with Chronic Hepatitis C-Virus in the Veteran Health Administration.
    Kramer JR, Richardson P, Liffmann D, El-Serag HB, Rein DB, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
  • Comparative Effectiveness of Screening of Hepatocellular Carcinoma in Veteran.
    Mittal S, Chung R, Sada Y, Kanwal F, Temple S, May SB, Ying J, Davila JA, El-Serag HB, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
  • Join now to see all

Lectures

  • Clinical Triad: Upper Gastrointestinal Tract 
    2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
  • "Writing and Speaking for Success" 
    Houston, TX - 1/20/2016
  • "Clinical Epidemiology, Lifestyle and Environmental Risk Factors" 
    Leesburg, VA - 1/3/2016
  • Join now to see all

Other

  • Screening for Gastric Cancer. 
    El-Serag HB, Cancer Screening, World Health Organization (WHO) Monograph
    1/1/2003
  • GERD 
    El-Serag HB, American Gastroenterology Association Monograph
    1/1/2002
  • Hepatitis C update (audiotape) 
    El-Serag HB, Clinical Advances in Gastroenterology
    1/1/2001

Press Mentions

  • Study Shows Synergistic Association Between Genetic and Behavioral Risks for Liver Disease
    Study Shows Synergistic Association Between Genetic and Behavioral Risks for Liver DiseaseOctober 3rd, 2022
  • Baylor Receives NCI Grant to Study Liver Cancer Risk and Prevention
    Baylor Receives NCI Grant to Study Liver Cancer Risk and PreventionAugust 4th, 2022
  • How We Approach It: Treatment Options for Hepatocellular Carcinoma
    How We Approach It: Treatment Options for Hepatocellular CarcinomaMay 1st, 2020
  • Join now to see all

Grant Support

  • Research Training In GasteroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
  • Program Leaders---Cancer PreventionNational Cancer Institute2010–2011
  • Epidemiology And Outcomes Of Digestive And Liver Diseases: A Mentoring ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
  • Obesity, H Pylori And Risk Of Barrett'S EsophagusNational Cancer Institute2007–2011
  • Comparative Effectiveness Of Screening And Surveillance EndoscopyNational Cancer Institute2010
  • Surveillance For Hepatocellular Carcinoma Among Hcv-Infected VeteransNational Cancer Institute2007–2009
  • Gene Expression In Barrett'S EsophagusNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006

Hospital Affiliations